Exocrine Pancreatic Insufficiency
"Exocrine Pancreatic Insufficiency" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS.
| Descriptor ID |
D010188
|
| MeSH Number(s) |
C06.689.276
|
| Concept/Terms |
Exocrine Pancreatic Insufficiency- Exocrine Pancreatic Insufficiency
- Exocrine Pancreatic Insufficiencies
- Insufficiencies, Exocrine Pancreatic
- Insufficiency, Exocrine Pancreatic
- Pancreatic Insufficiencies, Exocrine
- Pancreatic Insufficiency, Exocrine
- Pancreatic Insufficiency
- Insufficiencies, Pancreatic
- Insufficiency, Pancreatic
- Pancreatic Insufficiencies
|
Below are MeSH descriptors whose meaning is more general than "Exocrine Pancreatic Insufficiency".
Below are MeSH descriptors whose meaning is more specific than "Exocrine Pancreatic Insufficiency".
This graph shows the total number of publications written about "Exocrine Pancreatic Insufficiency" by people in this website by year, and whether "Exocrine Pancreatic Insufficiency" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2004 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 4 | 0 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 3 | 0 | 3 |
| 2024 | 1 | 0 | 1 |
| 2025 | 1 | 1 | 2 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Exocrine Pancreatic Insufficiency" by people in Profiles.
-
Gastrointestinal Burden in Patients With Pancreatic Insufficient Cystic Fibrosis Before and After Elexacaftor/Tezacaftor/Ivacaftor Use. Pancreas. 2025 Nov-Dec 01; 54(10):e858-e862.
-
Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction. Cell Stem Cell. 2013 Jun 06; 12(6):727-36.
-
Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults. Aliment Pharmacol Ther. 1997 Oct; 11(5):981-6.
-
Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet. 1995 May; 32(5):330-5.
-
Treatment of steatorrhea in chronic pancreatitis. Hosp Pract (Off Ed). 1986 Jan 15; 21(1):125-9.
-
Mechanism of increase in steatorrhea with calcium and magnesium in exocrine pancreatic insufficiency: an animal model. Gastroenterology. 1982 Sep; 83(3):638-44.
-
Pancreatic enzyme replacement: the effect of antacids or cimetidine. Dig Dis Sci. 1982 Jun; 27(6):485-90.